As of April 22, 2026, Natures Sunshine Products's top three insider holders are Partners Small Cap Value Lp Wynnefield (TenPercentOwner, 1.70Mn shares), Partners Small Cap Value Lp Wynnefield (TenPercentOwner, 1.70Mn shares), Partners Small Cap Value Lp Wynnefield (TenPercentOwner, 1.70Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Partners Small Cap Value Lp Wynnefield | - | 0 | 1,699,139 | 19 Sep, 2022 |
| Partners Small Cap Value Lp Wynnefield | - | 0 | 1,699,139 | 19 Sep, 2022 |
| Partners Small Cap Value Lp Wynnefield | - | 0 | 1,699,139 | 19 Sep, 2022 |
| Partners Small Cap Value Lp Wynnefield | - | 0 | 1,699,139 | 19 Sep, 2022 |
| Partners Small Cap Value Lp Wynnefield | - | 774,547 | 0 | 19 Sep, 2022 |
| Partners Small Cap Value Lp Wynnefield | - | 774,547 | 0 | 19 Sep, 2022 |
| Partners Small Cap Value Lp Wynnefield | - | 774,547 | 0 | 19 Sep, 2022 |
| Partners Small Cap Value Lp Wynnefield | - | 774,547 | 0 | 19 Sep, 2022 |
| Partners Small Cap Value Lp Wynnefield | - | 771,646 | 0 | 06 Sep, 2022 |
| Partners Small Cap Value Lp Wynnefield | - | 771,646 | 0 | 06 Sep, 2022 |
| Partners Small Cap Value Lp Wynnefield | - | 771,646 | 0 | 06 Sep, 2022 |
| Partners Small Cap Value Lp Wynnefield | - | 771,646 | 0 | 06 Sep, 2022 |
| Terrence Moorehead | Chief Executive Officer | 543,292 | 0 | 23 Jul, 2025 |
| Willem Mesdag | - | 0 | 524,997 | 17 Sep, 2021 |
| Joseph W Baty | Evp Chief Financial Officer | 173,702 | 0 | 25 Jul, 2022 |
| Kenneth G. Romanzi | Chief Executive Officer | 102,881 | 0 | 25 Mar, 2026 |
| Kenneth G. Romanzi | Chief Executive Officer | 102,881 | 0 | 25 Mar, 2026 |
| Leslie Shane Jones | Evp Chief Financial Officer | 101,016 | 0 | 21 Apr, 2026 |
| Bryant J Yates | Evp President, Europe | 75,826 | 0 | 21 Apr, 2026 |
| Martin A. Gonzalez | Evp, Global Supply Chain | 69,640 | 0 | 06 Nov, 2025 |
| Tracee Comstock | Vp, Human Resources | 64,449 | 0 | 23 Jul, 2025 |
| Fosun Pharmaceutical (Group) Co., Ltd. Shanghai | - | 0 | 64,167 | 17 Oct, 2024 |
| Fosun Pharmaceutical (Group) Co., Ltd. Shanghai | - | 0 | 64,167 | 17 Oct, 2024 |
| John Christopher Teets | - | 55,315 | 0 | 09 May, 2024 |
| John Christopher Teets | - | 55,315 | 0 | 09 May, 2024 |
| Robert D Straus | - | 52,014 | 0 | 06 May, 2025 |
| Robert D Straus | - | 52,014 | 0 | 06 May, 2025 |
| Edward Silcock | Evp President, North America | 51,486 | 0 | 25 Jul, 2022 |
| Edward Silcock | Evp President, North America | 51,486 | 0 | 25 Jul, 2022 |
| Kevin R. Herbert | Evp President, North America | 48,530 | 0 | 12 Mar, 2026 |
| Mary Beth Springer | - | 48,352 | 0 | 06 May, 2022 |
| Mary Beth Springer | - | 48,352 | 0 | 06 May, 2022 |
| Nathan G Brower | Evp, General Counsel | 42,345 | 0 | 21 Apr, 2026 |
| Daniel C Norman | Evp President, Asia | 40,428 | 0 | 21 Apr, 2026 |
| Jonathan David Lanoy | Svp, Chief Accounting Officer | 40,039 | 0 | 21 Apr, 2026 |
| Richard D Moss | - | 38,629 | 0 | 08 May, 2024 |
| Heidi Wissmiller | - | 37,167 | 0 | 06 May, 2025 |
| Heidi Wissmiller | - | 37,167 | 0 | 06 May, 2025 |
| Rong Yang | - | 30,249 | 0 | 06 May, 2025 |
| Rong Yang | - | 30,249 | 0 | 06 May, 2025 |
| Tess Roering | - | 29,927 | 0 | 06 May, 2025 |
| Tess Roering | - | 29,927 | 0 | 06 May, 2025 |
| Curtis Kopf | - | 29,927 | 0 | 06 May, 2025 |
| Kevin Gregory Fuller | Global Chief Marketing Officer | 29,425 | 0 | 12 Mar, 2026 |
| Sarah Crockett | Global Chief Marketing Officer | 26,873 | 0 | 13 Mar, 2024 |
| Steven J. Fasching | - | 10,869 | 0 | 07 May, 2025 |
| Erich A Fritz | Evp, Global Supply Chain | 10,760 | 0 | 25 Mar, 2026 |
| Katie May | - | 9,766 | 0 | 06 May, 2025 |
| Shirley Wu | - | 9,149 | 0 | 06 May, 2022 |
| Shirley Wu | - | 9,149 | 0 | 06 May, 2022 |
| Tariq Hassan | - | 3,119 | 0 | 06 Jul, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Apr, 2026 | Nathan G Brower | Common Shares | D | 1,289 | $27.07 | 42,345 | D | F |
| 20 Apr, 2026 | Bryant J Yates | Common Shares | D | 1,567 | $27.07 | 75,826 | D | F |
| 20 Apr, 2026 | Leslie Shane Jones | Common Shares | D | 3,512 | $27.07 | 101,016 | D | F |
| 20 Apr, 2026 | Daniel C Norman | Common Shares | D | 1,567 | $27.07 | 40,428 | D | F |
| 20 Apr, 2026 | Jonathan David Lanoy | Common Shares | D | 951 | $27.07 | 40,039 | D | F |
| 06 Mar, 2026 | Kenneth G. Romanzi | Common Shares | D | 29,928 | - | 102,881 | D | J |
| 06 Mar, 2026 | Erich A Fritz | Common Shares | D | 8,180 | - | 10,760 | D | J |
| 06 Mar, 2026 | Jonathan David Lanoy | Common Shares | D | 5,415 | - | 40,990 | D | J |
| 06 Mar, 2026 | Kevin R. Herbert | Common Shares | D | 7,124 | - | 41,406 | D | J |
| 06 Mar, 2026 | Daniel C Norman | Common Shares | D | 10,088 | - | 41,995 | D | J |
| 06 Mar, 2026 | Nathan G Brower | Common Shares | D | 7,250 | - | 43,634 | D | J |
| 06 Mar, 2026 | Leslie Shane Jones | Common Shares | D | 11,798 | - | 104,528 | D | J |
| 06 Mar, 2026 | Kevin Gregory Fuller | Common Shares | D | 7,965 | - | 21,460 | D | J |
| 06 Mar, 2026 | Kenneth G. Romanzi | Common Shares | D | 29,928 | - | 102,881 | D | J |
| 06 Mar, 2026 | Bryant J Yates | Common Shares | D | 7,761 | - | 77,393 | D | J |
| 13 Mar, 2026 | Bryant J Yates | Common Shares | D | 19,516 | $24.35 | 85,154 | D | S |
| 13 Mar, 2026 | Daniel C Norman | Common Shares | D | 15,383 | $24.52 | 55,693 | D | S |
| 13 Mar, 2026 | Daniel C Norman | Common Shares | D | 3,610 | $24.49 | 52,083 | D | G |
| 13 Mar, 2026 | Jonathan David Lanoy | Common Shares | D | 4,000 | $24.70 | 46,405 | D | S |
| 10 Mar, 2026 | Jonathan David Lanoy | Common Shares | D | 1,012 | $25.08 | 51,237 | D | F |